blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2285808

EP2285808 - SPIRO-INDOLE DERIVATIVES FOR THE TREATMENT OF PARASITIC DISEASES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  26.09.2014
Database last updated on 13.07.2024
Most recent event   Tooltip26.09.2014No opposition filed within time limitpublished on 29.10.2014  [2014/44]
Applicant(s)For all designated states
Novartis AG
Lichtstrasse 35
4056 Basel / CH
[2011/08]
Inventor(s)01 / ANG, Shi Hua
Novartis Institute for Tropical Diseases Pte Ltd
10 Biopolis Road
05-01 Chromos
Singapore 138670 / SG
02 / KRASTEL, Philipp
Novartis Pharma AG
Postfach
CH-4002 Basel / CH
03 / LEONG, Seh Yong
Novartis Institute for Tropical Diseases Pte Ltd
10 Biopolis Road
05-01 Chromos
Singapore 138670 / SG
04 / TAN, Liying Jocelyn
Novartis Institute for Tropical Diseases Pte Ltd
10 Biopolis Road
05-01 Chromos
Singapore 138670 / SG
05 / WONG, Wei Lin Josephine
Novartis Institute for Tropical Diseases Pte Ltd
10 Biopolis Road
05-01 Chromos
Singapore 138670 / SG
06 / YEUNG, Bryan KS
Novartis Institute for Tropical Diseases Pte Ltd
10 Biopolis Road
05-01 Chromos
Singapore 138670 / SG
07 / ZOU, Bin
Novartis Institute for Tropical Diseases Pte Ltd
10 Biopolis Road
05-01 Chromos
Singapore 138670 / SG
 [2013/47]
Former [2011/08]01 / ANG, Shi Hua
Novartis Institute for Tropical Diseases Pte Ltd 10 Biopolis Road 05-01 Chromos
Singapore 138670 / SG
02 / KRASTEL, Philipp
Novartis Pharma AG Postfach
CH-4002 Basel / CH
03 / LEONG, Seh Yong
Novartis Institute for Tropical Diseases Pte Ltd 10 Biopolis Road 05-01 Chromos
Singapore 138670 / SG
04 / TAN, Liying Jocelyn
Novartis Institute for Tropical Diseases Pte Ltd 10 Biopolis Road 05-01 Chromos
Singapore 138670 / SG
05 / WONG, Wei Lin Josephine
Novartis Institute for Tropical Diseases Pte Ltd 10 Biopolis Road 05-01 Chromos
Singapore 138670 / SG
06 / YEUNG, Bryan KS
Novartis Institute for Tropical Diseases Pte Ltd 10 Biopolis Road 05-01 Chromos
Singapore 138670 / SG
07 / ZOU, Bin
Novartis Institute for Tropical Diseases Pte Ltd 10 Biopolis Road 05-01 Chromos
Singapore 138670 / SG
Representative(s)Stuttle, James Henry Phillip
Novartis Pharma AG
Patent Department
4002 Basel / CH
[2014/01]
Former [2013/47]Warner, James Alexander
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
Former [2011/08]Warner, James Alexander
Carpmaels & Ransford One Southampton Row London
WC1B 5HA / GB
Application number, filing date09737965.501.04.2009
[2011/08]
WO2009EP53902
Priority number, dateEP2008015534229.04.2008         Original published format: EP 08155342
EP2009015111722.01.2009         Original published format: EP 09151117
[2011/08]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2009132921
Date:05.11.2009
Language:EN
[2009/45]
Type: A1 Application with search report 
No.:EP2285808
Date:23.02.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 05.11.2009 takes the place of the publication of the European patent application.
[2011/08]
Type: B1 Patent specification 
No.:EP2285808
Date:20.11.2013
Language:EN
[2013/47]
Search report(s)International search report - published on:EP05.11.2009
ClassificationIPC:C07D471/20, C07D487/20, A61K31/437, A61K31/55, A61K31/407, A61P33/02, A61P33/06, A61K31/424, A61K31/438, C07D498/22
[2011/08]
CPC:
C07D471/20 (EP,US); A61P31/00 (EP); A61P33/00 (EP);
A61P33/02 (EP); A61P33/06 (EP); A61P43/00 (EP);
C07D487/20 (EP,US); C07D498/22 (EP,US); Y02A50/30 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2011/08]
TitleGerman:SPIRO-INDOLDERIVATE ZUR BEHANDLUNG PARASITISCHER KRANKHEITEN[2011/08]
English:SPIRO-INDOLE DERIVATIVES FOR THE TREATMENT OF PARASITIC DISEASES[2011/08]
French:DÉRIVÉS SPIRO-INDOLES POUR LE TRAITEMENT DE MALADIES PARASITAIRES[2011/08]
Entry into regional phase10.11.2010National basic fee paid 
10.11.2010Designation fee(s) paid 
10.11.2010Examination fee paid 
Examination procedure10.11.2010Examination requested  [2011/08]
09.02.2011Amendment by applicant (claims and/or description)
11.04.2012Despatch of a communication from the examining division (Time limit: M04)
21.08.2012Reply to a communication from the examining division
25.02.2013Despatch of a communication from the examining division (Time limit: M04)
05.06.2013Reply to a communication from the examining division
30.08.2013Communication of intention to grant the patent
02.10.2013Fee for grant paid
02.10.2013Fee for publishing/printing paid
Divisional application(s)EP13185962.1  / EP2722333
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  11.04.2012
Opposition(s)21.08.2014No opposition filed within time limit [2014/44]
Fees paidRenewal fee
12.04.2011Renewal fee patent year 03
30.03.2012Renewal fee patent year 04
12.04.2013Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]EP0466548  (ADIR [FR]) [X] 1-3,6,7 * page 8; example 1 * * claim 5 *;
 [A]WO2005009370  (PHARMACIA CORP [US], et al) [A] 1-3,5-7 * page 6 - page 8; compound I * * page 300, paragraph 143 ** claim 12 *;
 [X]  - BREMNER JOHN B ET AL, "A compact approach to an isomeric iheyamine a system and x-ray crystal structure of 5-methyl-5H-azepino[2,3-b:4,5-b']diindole", SYNTHETIC COMMUNICATIONS, TAYLOR & FRANCIS GROUP, PHILADELPHIA, PA, vol. 38, no. 12, ISSN 0039-7911, (20080101), pages 1931 - 1939, (20080101), XP009115559 [X] 1-3 * page 1932; compound 5B *

DOI:   http://dx.doi.org/10.1080/00397910801997603
 [A]  - CHIYANZU IDAN ET AL, "Design, synthesis and anti-plasmodial evaluation in vitro of new 4-aminoquinoline isatin derivatives", BIOORGANIC & MEDICINAL CHEMISTRY, ELSEVIER SCIENCE LTD, GB, (20050101), vol. 13, no. 9, ISSN 0968-0896, pages 3249 - 3261, XP002482130 [A] 1-13 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.bmc.2005.02.037
 [A]  - HUDSON, A.T., "Patent focus on antiparasitic agents", EXPERT OPINION ON THERAPEUTIC PATENTS, (20000101), vol. 10, no. 2, pages 153 - 163, XP002527893 [A] 1-13 * the whole document *

DOI:   http://dx.doi.org/10.1517/13543776.10.2.153
Examination   - GRIGORYAN N P ET AL, "Synthesis and antispasmodic activity of spiro[.beta.-carbolineindolo nes] and spiro[indoleindolo[2,3-c]azepinones]", HAYASTANI KIMIAKAN HANDES, IZDATEL'STVO GITUTYN NAN RESPUBLIKI ARMENII, (20050101), vol. 58, no. 3, ISSN 1561-4190, pages 100 - 104, XP009102457
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.